Idioma:

Human MiniPromoters for ocular-rAAV expression in ON bipolar, cone, corneal, endothelial, Müller glial, and PAX6 cells

Korecki, Andrea J ; Cueva-Vargas, Jorge L ; Fornes, Oriol ; Agostinone, Jessica ; Farkas, Rachelle A ; Hickmott, Jack W ; Lam, Siu Ling ; Mathelier, Anthony ; Zhou, Michelle ; Wasserman, Wyeth W ; Di Polo, Adriana ; Simpson, Elizabeth M

Gene therapy, 2021-06, Vol.28 (6), p.351-372 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por

Enviar para

Título:
Human MiniPromoters for ocular-rAAV expression in ON bipolar, cone, corneal, endothelial, Müller glial, and PAX6 cells
Autor: Korecki, Andrea J ; Cueva-Vargas, Jorge L ; Fornes, Oriol ; Agostinone, Jessica ; Farkas, Rachelle A ; Hickmott, Jack W ; Lam, Siu Ling ; Mathelier, Anthony ; Zhou, Michelle ; Wasserman, Wyeth W ; Di Polo, Adriana ; Simpson, Elizabeth M
Assuntos: Animals ; Clinical trials ; Cornea ; Deoxyribonucleic acid ; Dependoviruses ; DNA ; Endothelial Cells ; Gene expression ; Gene therapy ; Genetic aspects ; Genetic engineering ; Genetic research ; Humans ; Intravenous administration ; Methods ; Mice ; Mueller cells ; Neonates ; Neuroglia ; Pax6 protein ; PAX6 Transcription Factor - genetics ; Promoter Regions, Genetic ; Promoters ; Promoters (Genetics) ; Retina ; Retinal Cone Photoreceptor Cells ; Stroma
É parte de: Gene therapy, 2021-06, Vol.28 (6), p.351-372
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
NFR/187615
Descrição: Small and cell-type restricted promoters are important tools for basic and preclinical research, and clinical delivery of gene therapies. In clinical gene therapy, ophthalmic trials have been leading the field, with over 50% of ocular clinical trials using promoters that restrict expression based on cell type. Here, 19 human DNA MiniPromoters were bioinformatically designed for rAAV, tested by neonatal intravenous delivery in mouse, and successful MiniPromoters went on to be tested by intravitreal, subretinal, intrastromal, and/or intravenous delivery in adult mouse. We present promoter development as an overview for each cell type, but only show results in detail for the recommended MiniPromoters: Ple265 and Ple341 (PCP2) ON bipolar, Ple349 (PDE6H) cone, Ple253 (PITX3) corneal stroma, Ple32 (CLDN5) endothelial cells of the blood-retina barrier, Ple316 (NR2E1) Müller glia, and Ple331 (PAX6) PAX6 positive. Overall, we present a resource of new, redesigned, and improved MiniPromoters for ocular gene therapy that range in size from 784 to 2484 bp, and from weaker, equal, or stronger in strength relative to the ubiquitous control promoter smCBA. All MiniPromoters will be useful for therapies involving small regulatory RNA and DNA, and proteins ranging from 517 to 1084 amino acids, representing 62.9-90.2% of human proteins.
Editor: England: Nature Publishing Group
Idioma: Inglês;Norueguês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 17 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Human MiniPromoters for ocular-rAAV expression in ON bipolar, cone, corneal, endothelial, Müller glial, and PAX6 cells

Korecki, Andrea J ; Cueva-Vargas, Jorge L ; Fornes, Oriol ; Agostinone, Jessica ; Farkas, Rachelle A ; Hickmott, Jack W ; Lam, Siu Ling ; Mathelier, Anthony ; Zhou, Michelle ; Wasserman, Wyeth W ; Di Polo, Adriana ; Simpson, Elizabeth M

England: Nature Publishing Group

Buscando em bases de dados remotas. Favor aguardar.